Single-agent expansion cohort of lenvatinib (LEN) and combination dose-finding cohort of LEN plus etoposide (ETP) plus ifosfamide (IFM) in patients (pts) aged 2 to <= 25 years with relapsed/refractory osteosarcoma (OS).

Autores de IIS La Fe

• Manuel Casanova Monroig

  Autor

• Adela Cañete Nieto

  Autor

Participantes ajenos a IIS La Fe

• Gaspar, N
• Sirvent, FJB
• Venkatramani, R
• Morland, B
• Gambart, M
• Thebaud, E
• Strauss, SJ
• Locatelli, F
• Melcon, SG
• Bielack, SS
• Rossig, C
• Aerts, I
• Marec-Berard, P
• Kraljevic, S
• Hayato, S
• He, CX
• Dutcus, CE
• Campbell-Hewson, Q

Grupos

• Investigación Clínica y Traslacional en Cáncer

Abstract

Abstract no disponible